Jim Simons Belite Bio, Inc Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Belite Bio, Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 4,300 shares of BLTE stock, worth $340,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,300Holding current value
$340,904% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding BLTE
# of Institutions
18Shares Held
76.4KCall Options Held
0Put Options Held
0-
State Street Corp Boston, MA20.2KShares$1.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12.9KShares$1.02 Million0.0% of portfolio
-
Marshall Wace, LLP London, X09.49KShares$752,0500.0% of portfolio
-
Jpmorgan Chase & CO New York, NY8.16KShares$647,0830.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.46KShares$591,1110.0% of portfolio
About BELITE BIO, INC
- Ticker BLTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,867,400
- Market Cap $1.97B
- Description
- Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery o...